GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for serine hydroxymethyltransferase (A4WDC0)

Analyse AlphaFold monomer V2.0 prediction for serine hydroxymethyltransferase (A4WDC0) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
A4WDC0
Type
protein
Length
417 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x9e5E98E011361C5888c92e2CDb7652E02Bd5C7Ed
Molecule
Serine hydroxymethyltransferase
UniProt
A4WDC0
Pockets
3 · best druggability 0.46

Structure

1 distinct chain · 49% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASerine hydroxymethyltransferaseprotein41749% helix, 13% strandA4WDC0

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11910.460.7532empty
21530.420.7422empty
3750.320.7418empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.